Veritas In Silico: Unconsolidated financial statements for the six-month period ending June 30, 2024 [based on Japanese accounting standards]
Veritas In Silico: Announcements of individual stocks regarding the achievement of milestones for joint drug discovery research with Takeda Pharmaceuticals sp adr.
Veritas In Silico: Notice regarding changes in officers
Veritas In Silico: Notice regarding a decrease in the amount of capital (capital reduction)
Veritas In Silico: Independent Officer Notification Form
Veritas In Silico: Articles of Incorporation 2023/08/18
Veritas In Silico: Notice Concerning Changes in Major Shareholders
Veritas In Silico: Matters relating to business plans and growth potential
Veritas In Silico: Notice of our financial results information etc. associated with listing on the Tokyo Stock Exchange Growth Market
Veritas In Silico: Confirmation of the appropriateness of securities reports, etc. for listing applications
Veritas In Silico: Quarterly Report for Listing Applications (3rd Quarter)
Veritas In Silico: Quarterly Report for Listing Applications (Q2)
Veritas In Silico: Quarterly Report for Listing Applications (First Quarter)
Veritas In Silico: securities reports for listing applications
No Data